Gookin K S, Forman E S, Vecchio T J, Wiser W L, Morrison J C
South Med J. 1983 Nov;76(11):1361-2, 1367. doi: 10.1097/00007611-198311000-00008.
Forty-two women with primary dysmenorrhea were successfully enrolled in a double-blind, three-way crossover study in which each patient received either ibuprofen (Motrin), indomethacin (Indocin), or a placebo during each of three successive painful menstrual cycles. Thirty-one patients successfully completed the study. The results showed that ibuprofen and indomethacin were superior to the placebo in their ability to relieve pain and that patients preferred ibuprofen to indomethacin. Ibuprofen was significantly superior to the placebo regarding the number of patients who could pursue normal daily function, whereas indomethacin was not. Four patients reported side effects, all during the indomethacin cycle.
42名原发性痛经女性成功入选一项双盲、三向交叉研究,在连续三个疼痛的月经周期中,每位患者分别接受布洛芬(摩特灵)、吲哚美辛(消炎痛)或安慰剂治疗。31名患者成功完成了研究。结果显示,布洛芬和吲哚美辛在缓解疼痛方面优于安慰剂,且患者更喜欢布洛芬而非吲哚美辛。在能够进行正常日常活动的患者数量方面,布洛芬显著优于安慰剂,而吲哚美辛则不然。4名患者报告了副作用,均出现在吲哚美辛治疗周期。